Biochemical efficacy and tolerability of allopurinol 300 - 600 mg/day versus benzbromarone 100 - 200 mg/day in GOUT patients

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2007
This article has no abstract
Epistemonikos ID: db1630e32fe0faf24fe1bb734ce59d1abb90023f
First added on: Jan 17, 2025